Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heavy metal salts represent a diverse group of inorganic or organic compounds containing dense metallic elements such as lead, mercury, arsenic, and cadmium. These substances are primarily recognized as environmental and occupational toxicants rather than therapeutic targets in the conventional sense of drug discovery. Their toxicity is fundamentally driven by their high affinity for sulfhydryl (-SH) groups on essential proteins and enzymes, leading to widespread enzymatic inhibition and structural damage (NIH, 2023). This interference disrupts critical cellular processes, including oxidative stress regulation and DNA repair, which manifests clinically as severe neurotoxicity, nephrotoxicity, and hematologic impairment (StatPearls, 2024). In a pharmacological context, these salts are the pathogens sequestered by chelating agents. Drugs such as dimercaprol, succimer, and penicillamine function as ligands that coordinate with the metal ions to form stable, water-soluble complexes (PubChem, 2024). This process neutralizes the toxicant and promotes its elimination from the body, although the management of such poisoning must account for the potential redistribution of metals during the treatment process.
Chelation therapy involves the administration of multi-dentate ligands that form stable, non-toxic, and water-soluble complexes with heavy metal ions, thereby preventing their interaction with cellular macromolecules and facilitating their systemic excretion via renal or biliary routes.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heavy metal salt.